[The use of deslorelin acetate (Suprelorin®) in companion animal medicine].
In 2009 Suprelorin® was released in Switzerland for the temporary suppression of fertility in male dogs. However, in practice it has also been used to treat other conditions in male dogs and in bitches. These include treatment of benign hyperplasia of the prostate, the induction or suppression of oestrus and treatment for the side effects of gonadectomy. Also in feline reproductive medicine GnRH-agonists gain increased importance. These areas of application are listed here in terms of treatment success and possible adverse effects after treatment of which owners have to be informed beforehand.
Klinik für Fortpflanzungsmedizin der Universität Zürich, Zürich. jpalm@vetclinics.uzh.ch
J
J
Palm
I M
IM
Reichler
D000818:Animals; D002371:Cat Diseases / Q000188:drug therapy*; D002415:Cats; D004283:Dog Diseases / Q000188:drug therapy*; D004285:Dogs; D004791:Enzyme Inhibitors / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D004971:Estrus / Q000187:drug effects; D005260:Female; D005298:Fertility / Q000187:drug effects*; D008297:Male; D010052:Ovariectomy / Q000009:adverse effects / Q000662:veterinary; D011470:Prostatic Hyperplasia / Q000188:drug therapy / Q000662:veterinary; D017329:Triptorelin Pamoate / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D014549:Urinary Incontinence / Q000188:drug therapy / Q000209:etiology / Q000662:veterinary
D004791:Enzyme Inhibitors; D017329:Triptorelin Pamoate; C066438:deslorelin